Loading...

World-Class Retina Care. Community-Based Caring.

Three New Clinical Trials Available at Texas Retina

Posted On October 31, 2023 / By / Posted in Blog

Three New Clinical Trials Available at Texas Retina

Medical researchers continue to make significant advances in the diagnosis and treatment of retinal conditions, and our physicians remain committed to participating in clinical trials that will improve care for our patients.

read more
Posted On February 21, 2023 / By / Posted in Blog

FDA Approves First Treatment for Geographic Atrophy

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved intravitreal pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Texas Retina

read more
Posted On June 14, 2022 / By / Posted in Blog

Dr. Abbey’s Research Featured in New Retina Podcast

The medical journal Retina recently released a podcast featuring research by Texas Retina Associates’ Ashkan M. Abbey, MD, on clinical outcomes and surgical technique in transconjunctival sutureless intrascleral fixation of intraocular lenses

read more
Posted On April 4, 2022 / By / Posted in Blog

Meet Our Dallas Clinical Research Coordinators

Karen Duignan, Sally Arceneaux, Ashley Hughes and Jessica Flores serve as our clinical research coordinators for Dallas. They assist patients with their enrollment and participation in our wide variety of clinical trials

read more